Abstract
SummaryBioartificial organ systems are becoming more attractive options for end‐stage organ disease. Currently, end‐stage liver disease has several palliative options but relies on transplantation for curative management. A new bioartificial liver has been approved for clinical trials in China and helps support the failed liver via stem cells.
Subject
Biomedical Engineering,General Medicine,Biomaterials,Medicine (miscellaneous),Bioengineering